Data: Limited
Tetrahydrocannabinol
Other Concerns
Use restrictions (high), Neurotoxicity (low), Endocrine disruption (low), Non-reproductive organ system toxicity (low), and Irritation (skin, eyes, or lungs) (low)SYNONYMS
EWG VERIFIED CRITERIA
Unacceptable: EWG VERIFIED products cannot contain this ingredient. EWG's criteria are updated annually, and companies with impacted products must reformulate per EWG Verified compliance schedules.
Common concerns
See how this product scores for common concerns.
-
LOWCancer
-
LOWAllergies & Immunotoxicity
-
LOWDevelopmental and Reproductive Toxicity
-
HIGHUse Restrictions
Ingredient concerns
- CONCERNS
- DATA SOURCES
Products with this Ingredient
| serums & essences | 1 products |
Use restrictions
| CONCERN | REFERENCE |
|---|---|
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | Health Canada |
Neurotoxicity
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show effects at moderate doses | Cannabis-induced impairment of learning and memory: effect of different nootropic drugs(2013-01-01) |
| One or more animal studies show neurological effects at moderate doses | Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol(1984-01-01) |
Developmental/reproductive toxicity
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show male reproductive system effects at moderate doses | Testicular toxicity in cannabis extract treated mice: association with oxidative stress and role of antioxidant enzyme systems(2010-02-01) |
| One or more animal studies show male reproductive effects at moderate doses | Maternal cannabinoid exposure Effects on spermatogenesis in male offspring.(1986-08-01) |
| One or more animal studies show effects at moderate doses | Quantitative evaluation of spermatogenesis in mice following chronic exposure to cannabinoids(1991-03-01) |
Irritation (skin, eyes, or lungs)
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show eye irritation at moderate doses | Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol(1984-01-01) |
Organ system toxicity (non-reproductive)
| CONCERN | REFERENCE |
|---|---|
| Limited evidence of toxicity | Cannabinoids for Medical Use: A Systematic Review and Meta-analysis(2015-06-23) |
| One or more animal studies show no adverse liver effects at moderate doses | Perinatal cannabinoid exposure: effects on hepatic cytochrome P-450 and plasma protein levels in male mice(1986-04-01) |
Endocrine disruption
| CONCERN | REFERENCE |
|---|---|
| Associated with endocrine disruption | Marijuana extracts possess the effects like the endocrine disrupting chemicals(2005-01-01) |
Allergies/immunotoxicity
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show or allergenic effects at moderate doses | Allergenic properties of naturally occurring cannabinoids(1983-08-01) |
- Health Canada
- Cannabis-induced impairment of learning and memory: effect of different nootropic drugs(2013-01-01)
- Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol(1984-01-01)
- Testicular toxicity in cannabis extract treated mice: association with oxidative stress and role of antioxidant enzyme systems(2010-02-01)
- Maternal cannabinoid exposure Effects on spermatogenesis in male offspring.(1986-08-01)
- Quantitative evaluation of spermatogenesis in mice following chronic exposure to cannabinoids(1991-03-01)
- Cannabinoids for Medical Use: A Systematic Review and Meta-analysis(2015-06-23)
- Perinatal cannabinoid exposure: effects on hepatic cytochrome P-450 and plasma protein levels in male mice(1986-04-01)
- Marijuana extracts possess the effects like the endocrine disrupting chemicals(2005-01-01)
- Allergenic properties of naturally occurring cannabinoids(1983-08-01)
Understanding scores
Cosmetics and personal care products are not required to be tested for safety before being allowed on the market. The Skin Deep® scoring system was designed to help the public understand whether a product is safe to use or whether it contains ingredients of concern.
Every product and ingredient in Skin Deep gets a two-part score – one for hazard and one for data availability. The safest products score well by both measures, with a low hazard rating and a fair or better data availability rating.
HOW WE DETERMINE SCORES
Hazard score
The Skin Deep ingredient hazard score, from 1 to 10, reflects known and suspected hazards linked to the ingredients. The EWG Verified® mark means a product meets EWG’s strictest criteria for transparency and health.
Data availability
The Skin Deep data availability rating reflects the number of scientific studies about the product or ingredient in the published scientific literature.